The global animal vaccine market size reached a value of around USD 10.5 billion in 2022, driven by new technological advances and emergence of new diseases/virus. The market is further expected to grow at a CAGR of 7% during the forecast period of 2023-2031, likely to attain a value of around USD 19.2 billion by 2031.
Animal vaccine or veterinary vaccines are given to animals to increase their life, prevent development or transmission of diseases. Vaccines are used to develop immunity of the animal against viral, bacterial, protozoal and other infections. Non-pathogenic components that can induce an immune response are present in the vaccine to develop acquired immunity in the animals. Vaccination can prevent the development of infectious disease upon exposure of the animal to the infection due to the presence of existing antibodies.
The growth of the market is primarily being driven by the rising technological advances, emergence of new diseases and development of drug resistance by pathogens . Technological advances in biotechnology field is leading to the development of DNA Vaccines, Vectored Vaccines, Subunit Vaccines and Recombinant Vaccines for broader safety, disease coverage and improved efficacy of the vaccine against the disease. Vaccines prevent the occurrence of infectious diseases and reduces the reliance of treating the disease on antibiotics that leads to development of drug resistant bacteria. During the emergence of new disease, vaccines can play an important role in preventing and curbing the transmission of disease by vaccinating the susceptible animals in the disease prone areas.
Based on segments, the market is divided into animal type, technology, diseases, route of administration, and region.
Market Breakup by Animal Type
Market Breakup by Technology
Market Breakup by Diseases
Animal Vaccine Market Breakup by Route of Administration
Market Breakup by Distribution Channels
Market Breakup by Region
The growth of the market is driven by the need of preventing and controlling the diseases in livestock animals. Heathy animals are directly equivalent to more mating possibilities, a greater number of births and eventually more animal produced food. Food sourced from animals, like eggs, milk, and meat, are the sources of high-quality protein, required for development of body which are also attributing the growth of the market.
Rising awareness about the importance of animal vaccination, along with various campaigns done by the government and NGOs have contributed to the increased awareness about the importance of these vaccines. The rising awareness among farmers about keeping their animals disease and virus free by getting them vaccinated timely can help them have better output and reduce the risk of transmission of infection among their animals.
The comprehensive EMR report provides an in-depth assessment of the market based on Porter's five forces model, along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global animal vaccine market, covering their competitive landscape and the latest developments like mergers, acquisitions, investments, and expansion plans.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.
|Scope of the Report||
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|Breakup by Animal Type||
|Breakup by Technology||
|Breakup by Diseases||
|Breakup by Route of Administration||
|Breakup by Distribution Channel||
|Breakup by Region||
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Animal Vaccine Market Overview
3.1 Global Animal Vaccine Market Historical Value (2016-2022)
3.2 Global Animal Vaccine Market Forecast Value (2023-2031)
4 Global Animal Vaccine Market Landscape
4.1 Global Animal Vaccine Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Animal Vaccine Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Indications
5 Global Animal Vaccine Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Animal Vaccine Market Segmentation
6.1 Global Animal Vaccine Market by Animal Type
6.1.1 Market Overview
6.1.5 Companion Animals
6.2 Global Animal Vaccine Market by Technology
6.2.1 Market Overview
6.2.2 Inactive Vaccine
6.2.3 Live Attenuated Vaccine
6.2.4 Toxoid Vaccine
6.2.5 Recombinant Vaccine
6.3 Global Animal Vaccine Market by Diseases
6.3.1 Market Overview
6.3.2 Foot and Mouth Diseases
6.3.3 New Castle Disease
6.3.4 Infectious Bronchitis
6.3.5 Infectious Bursal Disease
6.3.6 Fowl Pox
6.4 Global Animal Vaccine Market by Route of Administration
6.4.1 Market Overview
6.5 Global Animal Vaccine Market by Distribution Channel
6.5.1 Market Overview
6.5.2 Veterinary Hospitals
6.5.3 Veterinary Clinics
6.6 Global Animal Vaccine Market by Region
6.6.1 Market Overview
6.6.2 North America
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Animal Vaccine Market
7.1 Market Share by Country
7.2 United States of America
8 Europe Animal Vaccine Market
8.1 Market Share by Country
8.2 United Kingdom
9 Asia Pacific Animal Vaccine Market
9.1 Market Share by Country
10 Latin America Animal Vaccine Market
10.1 Market Share by Country
11 Middle East and Africa Animal Vaccine Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.5 South Africa
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
17 Supplier Landscape
17.1 Zoetis, Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.2 Boehringer Ingelheim International GmbH
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisition
17.3 Elanco Animal Health Incorporated
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.4 Merck & Co., Inc.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.5 Ceva Sante Animale SA
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.6 Bayer AG
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.7 Virbac SA
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.8 Neogen Corporation
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.9 ImmuCell Corporation
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.10 Covetrus, Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
18 Global Animal Vaccine Market - Distribution Model (Additional Insight)
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
*Additional insights provided are customisable as per client requirements.
The market attained a value of USD 10.5 billion in 2022, driven by the rising technological advances, emergence of new diseases and development of drug resistance by pathogens.
The market is anticipated to grow at a CAGR of 7% during the forecast period of 2023-2031 to attain a value of around USD 19.2 billion by 2031.
The growth of the market is driven by factors like the rising technological advances, emergence of new diseases, development of drug resistance by pathogens, and increased awareness among farmers and veterinarians.
The key trends which are bolstering the market growth include customized vaccines for specific pathogens, rise in zoonotic diseases, and increased focus on prevention of diseases.
The product types in the market include inactive vaccine, live attenuated vaccine, toxoid vaccine, recombinant vaccine and others.
The diseases can be divided into foot and mouth diseases, new castle disease, infectious bronchitis, infectious bursal diseases, fowl pox, rabies.
The distribution channels are veterinary hospitals, veterinary clinics, pharmacies.
The major regional markets include North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
The key players in the market can be categorised into Zoetis, Inc., Boehringer Ingelheim International GmbH, Elanco Animal Health Incorporated, Merck & Co., Inc., Virbac SA, Neogen Corporation, ImmuCell Corporation, Covetrus, Inc., Ceva Sante Animale SA., and Bayer AG.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.